Article Details
Retrieved on: 2020-12-18 20:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Original Filings. Kinnate <b>Biopharma</b> (KNTE). OrbiMed Advisors revealed a fresh position in the cancer-focused <b>biopharmaceutical</b> of 3,397,929 shares, ...
Article found on: www.barrons.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here